Company news
Huadong Medicine Co., Ltd. Class A (SZSE:000963) news
Huadong Medicine Co., Ltd. Class A news releases on 6ix. Latest, Mar 6, 2026: CARsgen Therapeutics Announces 2025 Annual Results
Press releases & updates
CARsgen Therapeutics Announces 2025 Annual Results
March 6, 2026
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87
October 9, 2025
Huadong Medicine Announces Positive Preliminary Results from a Phase Ⅰ study of HDM2005, a ROR1-Targeting ADC
September 5, 2025
Vcare Enters into Exclusive Partnership with Huadong Medicine to Commercialize its second-generation JAK1 inhibitor, VC005 tablets, in China
August 15, 2025
CARsgen Therapeutics Announces 2025 Interim Results
August 13, 2025